Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-048600
Filing Date
2021-12-16
Accepted
2021-12-16 16:15:10
Documents
2
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2159
2 EX-24 DOCUMENT attachment1.htm EX-24 3841
  Complete submission text file 0000899243-21-048600.txt   7408
Mailing Address 58 S SERVICE RD MELVILLE NY 11747
Business Address
ONETTO NICOLE (Reporting) CIK: 0001220049 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39988 | Film No.: 211497937

Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Issuer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations